METROPOLIS

Metropolis Healthcare Share Price

₹2,061.85 +46.1 (2.29%)

24 Nov, 2024 09:54

SIP TrendupStart SIP in METROPOLIS

Start SIP

Performance

  • Low
  • ₹2,010
  • High
  • ₹2,071
  • 52 Week Low
  • ₹1,450
  • 52 Week High
  • ₹2,318
  • Open Price₹2,010
  • Previous Close₹2,016
  • Volume106,266

Investment Returns

  • Over 1 Month -2.81%
  • Over 3 Month -0.16%
  • Over 6 Month + 5.91%
  • Over 1 Year + 27.09%
SIP Lightning

Smart Investing Starts Here Start SIP with Metropolis Healthcare for Steady Growth!

Invest Now

Metropolis Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 71.4
  • PEG Ratio
  • 6.5
  • Market Cap Cr
  • 10,571
  • P/B Ratio
  • 9.6
  • Average True Range
  • 65.35
  • EPS
  • 28.87
  • Dividend Yield
  • 0
  • MACD Signal
  • -26.98
  • RSI
  • 43.22
  • MFI
  • 45.01

Metropolis Healthcare Financials

Metropolis Healthcare Technicals

EMA & SMA

Current Price
₹2,061.85
+ 46.1 (2.29%)
pointer
  • stock-down_img
  • Bullish Moving Average 5
  • stock-up_img
  • Bearish Moving Average 11
  • 20 Day
  • ₹2,100.80
  • 50 Day
  • ₹2,126.91
  • 100 Day
  • ₹2,088.69
  • 200 Day
  • ₹1,973.33

Resistance and Support

2047.73 Pivot Speed
  • R3 2,146.97
  • R2 2,109.18
  • R1 2,085.52
  • S1 2,024.07
  • S2 1,986.28
  • S3 1,962.62

What's your outlook on Metropolis Healthcare?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Metropolis Healthcare Ltd. is a leading diagnostic service provider in India, offering a wide range of pathology tests and healthcare solutions. With an extensive network of labs and collection centers, it serves patients across India and international markets.

Metropolis Healthcare has an operating revenue of Rs. 1,285.26 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 14% is healthy, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 28 indicates it belongs to a strong industry group of Medical-Services and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Metropolis Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-08 Quarterly Results
2024-08-10 Quarterly Results
2024-05-21 Audited Results
2024-02-02 Quarterly Results
2023-11-04 Quarterly Results & Interim Dividend
Date Purpose Remarks
2023-11-17 INTERIM Rs.4.00 per share(200%)Interim Dividend
2023-02-23 INTERIM Rs.8.00 per share(400%)Interim Dividend (Revised)
2022-02-22 INTERIM Rs.8.00 per share(400%)Interim Dividend
2021-02-19 INTERIM Rs.8.00 per share(400%)Interim Dividend

Metropolis Healthcare F&O

Metropolis Healthcare Shareholding Pattern

49.43%
24.33%
3.56%
18.56%
3.54%
0.58%

About Metropolis Healthcare

  • NSE Symbol
  • METROPOLIS
  • BSE Symbol
  • 542650
  • Managing Director
  • Mrs. Ameera Sushil Shah
  • ISIN
  • INE112L01020

Similar Stocks to Metropolis Healthcare

Metropolis Healthcare FAQs

Metropolis Healthcare share price is ₹2,061 As on 24 November, 2024 | 09:40

The Market Cap of Metropolis Healthcare is ₹10570.5 Cr As on 24 November, 2024 | 09:40

The P/E ratio of Metropolis Healthcare is 71.4 As on 24 November, 2024 | 09:40

The PB ratio of Metropolis Healthcare is 9.6 As on 24 November, 2024 | 09:40

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23